arrow
B

Boris Sepesi

The University of Texas MD Anderson Cancer Center
H指数:55
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2026 Revised Recommendations of The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer:

2026年美国胸外科医师学会(AATS)2023年专家共识文件的修订建议:早期非小细胞肺癌的分期和多学科管理:

2026-09-250
OA
Nationwide Implementation of Neoadjuvant Nivolumab-Based Chemo-Immunotherapy for Resectable NSCLC: Surgical Outcomes from a Prospective Multicenter Study

全国范围内新辅助纳武利尤单抗为基础的化疗免疫疗法在可切除非小细胞肺癌中的应用:一项前瞻性多中心研究的手术结果

2026-07-300
OA
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multi-Center Retrospective Study

肺肉瘤样癌的特定临床基因组学特征及与免疫治疗的相关性:一项多中心回顾性研究

2025-07-250
OAAI
Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types

肠道微生物组中富集的通路预测不同人口地区和多种癌症类型对免疫检查点抑制剂治疗的反应

2025-04-010
OAAI
Neoadjuvant nivolumab and nivolumab plus ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159

新辅助纳武利尤单抗及纳武利尤单抗联合伊匹木单抗在可切除非小细胞肺癌中的应用:NEOSTAR和CA209-159研究的5年结果联合分析

2024-09-010
PRE
Perioperative Nivolumab in Resectable Lung Cancer

可切除肺癌的围手术期Nivolumab

2024-05-1645
PRE
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Network
2024-05-012
PRE
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept

CT合成PET改善肺癌的诊断和预后: 概念验证

2024-03-013
OAAI
An atlas of epithelial cell states and plasticity in lung adenocarcinoma

肺腺癌上皮细胞状态和可塑性的图谱

Nature
IF48.5
2024-02-280
OAAI
CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage IIeIIIb NSCLC

CheckMate 77T: III期研究比较了新辅助nivolumab (NIVO) 加化学疗法 (chemo) 与新辅助安慰剂加化学疗法,然后进行手术和辅助NIVO或安慰剂,用于先前未经治疗的,可切除的IIeIIIb期NSCLC

2023-10-0167
OAAI
Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations

胸膜间皮瘤对新辅助治疗的影像学反应应作为患者选择减瘤手术的指南

2023-08-110
OAAI
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
2023-07-0127
OAAI